News

BioPharma Dive4d
With Verona deal, Merck wagers on strength of lung drug’s patents
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
MedCity News6d
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...
YouTube Is Shutting Down Its General ‘Trending’ Video Page
YouTube is shutting down its "Trending" sections, saying that there are better ways for users to find viral videos on the ...
YouTube Will Get Rid of Its Main Trending List As Viewing Habits Shift
Viewers will still receive personalized recommendations from YouTube. YouTube will also still continue to provide creators ...
YouTube ‘clarifies’ its plan to demonetize spammy AI slop
“YouTube has always required creators to upload ‘original’ and ‘authentic’ content,” YouTube said in its initial notification ...
YouTube's New Monetisation Rules From July 15: A Warning For AI Creators? Here's What's Changing
YouTube’s new monetisation policy, effective July 15, 2025, targets mass-produced, AI-generated, and low-effort content ...
Explore more
YouTube prepares crackdown on ‘mass-produced’ and ‘repetitive’ videos, as concern over AI slop grows
YouTube is preparing to update its policies to crack down on creators’ ability to generate revenue from “inauthentic” content ...
Fierce Pharma6d
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...